arrow
L

Laurent Servais

University of Oxford
H指数:63
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of European registries to characterise the changing landscape of disease progression and treatment of spinal muscular atrophy (SMA): opportunities, pitfalls and challenges

利用欧洲注册登记研究表征脊髓性肌萎缩症(SMA)疾病进展和治疗变化格局:机遇、陷阱与挑战

2026-08-050
OA
Health economic evaluations of genomic newborn screening: Approaches by studies within the international consortium on newborn sequencing

基因组新生儿筛查的健康经济学评价:国际新生儿测序联盟内各研究的方法

2026-06-040
PRE
A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy

SAPPHIRE临床试验的简明语言摘要,该试验研究apitegromab在儿童和年轻成人脊髓性肌萎缩症患者中的应用。

2025-11-130
OAAI
Trach and treat: Safety and motor outcomes following onasemnogene abeparvovec in patients with spinal muscular atrophy and tracheostomies in the RESTORE registry

气管切开与治疗:RESTORE登记研究中,接受onasemnogene abeparvovec治疗的气管切开术患者的脊髓性肌萎缩症患者的安全性与运动结局

2025-11-110
OA
Re-evaluating acceptable risk of death from gene therapy: A threshold study among individuals with Duchenne muscular dystrophy and their caregivers in the US and UK

重新评估基因治疗的可接受死亡风险:一项在美国和英国杜氏肌营养不良症患者及其护理人员中的阈值研究

2025-10-010
OAAI